Weiss Multi Strategy Advisers LLC Aclaris Therapeutics, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

  • $0
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$6.56 - $10.95 $462,965 - $772,785
-70,574 Reduced 58.35%
50,368 $345,000
Q2 2023

Aug 14, 2023
BUY
$7.89 - $10.64 $489,022 - $659,467
61,980 Added 105.12%
120,942 $1.25 Million
Q1 2023

May 15, 2023
BUY
$7.07 - $17.95 $416,861 - $1.06 Million
58,962 New
58,962 $477,000
Q2 2022

Aug 15, 2022
BUY
$10.16 - $17.08 $152,400 - $256,199
15,000 New
15,000 $209,000

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $193M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email